Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions Inc (BLFS)
:BLFS
BLFS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$19.10 - $29.55
Previous CloseN/A
Volume44.73K
Average Volume (3M)476.20K
Market Cap
$1.21B
Enterprise Value$971.62M
Total Cash (Recent Filing)$81.77M
Total Debt (Recent Filing)$23.82M
Price to Earnings (P/E)―
Beta2.04
Next Earnings
Nov 06, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding47,905,266
10 Day Avg. Volume648,709
30 Day Avg. Volume476,202
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue12.70
Enterprise Value/Gross Profit15.36
Enterprise Value/Ebitda-120.37
Forecast
1Y Price Target
$30.78Price Target Upside21.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBiolife reported 2Q25 results with revenue up 29% year-over-year, beating consensus estimates and showing strong financial performance.
Revenue GuidanceManagement raised the 2025 revenue guidance to $100-103M, indicating confidence in continued growth and performance.
Strategic ExpansionThe acquisition of PanTHERA Cryosolutions is part of Biolife's growth strategy, enhancing its product offerings and market position.
Bears Say
EarningsDespite the strong performance, the company still expects a reduction in net loss and expansion of Adj. EBITDA, with a path to Adj. EBITDA margin scaling into the 30%s long term.
Gross MarginsGross margins fell a bit in the second quarter, to 62% from 64%.
BioLife Solutions News
BLFS FAQ
What was BioLife Solutions Inc’s price range in the past 12 months?
BioLife Solutions Inc lowest stock price was $19.10 and its highest was $29.55 in the past 12 months.
What is BioLife Solutions Inc’s market cap?
BioLife Solutions Inc’s market cap is $1.21B.
When is BioLife Solutions Inc’s upcoming earnings report date?
BioLife Solutions Inc’s upcoming earnings report date is Nov 06, 2025 which is in 82 days.
How were BioLife Solutions Inc’s earnings last quarter?
BioLife Solutions Inc released its earnings results on Aug 07, 2025. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of -$0.034 by -$0.296.
Is BioLife Solutions Inc overvalued?
According to Wall Street analysts BioLife Solutions Inc’s price is currently Undervalued.
Does BioLife Solutions Inc pay dividends?
BioLife Solutions Inc does not currently pay dividends.
What is BioLife Solutions Inc’s EPS estimate?
BioLife Solutions Inc’s EPS estimate is -0.01.
How many shares outstanding does BioLife Solutions Inc have?
BioLife Solutions Inc has 47,905,266 shares outstanding.
What happened to BioLife Solutions Inc’s price movement after its last earnings report?
BioLife Solutions Inc reported an EPS of -$0.33 in its last earnings report, missing expectations of -$0.034. Following the earnings report the stock price went up 9.884%.
Which hedge fund is a major shareholder of BioLife Solutions Inc?
Currently, no hedge funds are holding shares in BLFS
BioLife Solutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.78 (21.56% Upside)
$30.78 (21.56% Upside)
Blogger Sentiment
Bullish
BLFS Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 338.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $35.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.51%
12-Months-Change
Fundamentals
Return on Equity
-5.98%
Trailing 12-Months
Asset Growth
3.27%
Trailing 12-Months
Company Description
BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
BLFS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth, increased guidance, and strategic investments, indicating strong operational performance and future potential. However, the increase in operating expenses and net loss, primarily due to noncash charges, tempered the overall financial results. The company's strong cash position and strategic investments position it well for future growth, despite near-term financial challenges.View all BLFS earnings summariesBLFS Revenue Breakdown
45.91% Cell processing
36.05% Freezer and thaw
18.04% Biostorage services
BLFS Stock 12 Month Forecast
Average Price Target
$30.78
▲(21.56% Upside)
Technical Analysis
Ownership Overview
19.86% Insiders
24.82% Mutual Funds
0.45% Other Institutional Investors
38.28% Public Companies and
Individual Investors